# RHAPSIDO

NDC: 0078-1483
Generic name: remibrutinib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250930

FDA application: NDA218436

## Active ingredients

- REMIBRUTINIB: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1483"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1483
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5e89bff-6ced-4165-acc5-fb13136b3a3d